Chapter 1. Maltogenic Alpha-Amylase Market – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. Maltogenic Alpha-Amylase Market – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

       2.3.1. Impact during 2023 - 2030

       2.3.2. Impact on Supply – Demand

Chapter 3. Maltogenic Alpha-Amylase Market – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. Maltogenic Alpha-Amylase Market Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. Maltogenic Alpha-Amylase Market - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. Maltogenic Alpha-Amylase Market – By Application

6.1 Bread

6.2. Cookies

6.3. Butter

6.4. Desserts

6.5. Others

Chapter 7. Maltogenic Alpha-Amylase Market – By End-Use

7.1. Bakery

7.2. Animal Feed

7.3. Biofuels

7.4. Sugar Products

7.5. Detergents

7.6. Others

Chapter 8. Maltogenic Alpha-Amylase Market- By Region

8.1. North America

8.2. Europe

8.3. Asia-Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9. Maltogenic Alpha-Amylase Market – key players

9.1 Novozymes A/S

9.2 Dupont de Nemours, Inc

9.3 Royal DSM N.V

9.4 Puratos N.V

9.5 AB Enzymes

9.6 Actavis plc

9.7 Biolaxi Corporation

9.8 Calzyme, Inc

9.9 Enmex S.A.

9.10 Danisco A/S